A personalized nomogram for predicting 3-year overall survival of patients with uterine carcinosarcoma in a tertiary care hospital in Southern Thailand
Authors:
Open Access
- 15 May 2023
- journal article
- research article
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 66 (3) , 198-207
Abstract
Objective To develop a nomogram for predicting 3-year overall survival (OS) and outcomes of surgically staged patients with uterine carcinosarcomas (UCS).Methods This retrospective study analyzed the clinicopathological characteristics, treatment data, and oncological outcomes of 69 patients diagnosed with UCS between January 2002 and September 2018. Significant prognostic factors for OS were identified and integrated to develop a nomogram. Concordance probability (CP) was used as a precision measure. The model was internally validated using bootstrapping samples to correct overfitting.Results The median follow-up time was 19.4 months (range, 0.77-106.13 months). The 3-year OS was 41.8% (95% confidence interval [CI], 29.9-58.3%). The International Federation of Gynecology and Obstetrics (FIGO) stage and adjuvant chemotherapy were independent factors for OS. The CP of the nomogram integrating with body mass index (BMI), FIGO stage, and adjuvant chemotherapy was 0.72 (95% CI, 0.70-0.75). In addition, the calibration curves for the probability of 3-year OS demonstrated good agreement between the nomogram-predicted and observed data.Conclusion The established nomogram using BMI, FIGO stage, and adjuvant chemotherapy accurately predicted the 3-year OS of patients with UCS. The nomogram was useful for patient counselling and deciding on follow-up strategies.Keywords
Funding Information
- Faculty of Medicine, Prince of Songkla University
This publication has 25 references indexed in Scilit:
- A nomogram to predict postresection 5‐year overall survival for patients with uterine leiomyosarcomaCancer, 2011
- Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-AnalysisCancer Epidemiology, Biomarkers & Prevention, 2010
- A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: Toward improving individualized cancer careGynecologic Oncology, 2010
- The impact of multi-modal therapy on survival for uterine carcinosarcomasGynecologic Oncology, 2010
- The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomasGynecologic Oncology, 2009
- Patterns of Failure for Conservatively Managed Surgical Stage I Uterine CarcinosarcomaInternational Journal of Gynecological Cancer, 2009
- Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?American Journal of Obstetrics and Gynecology, 2008
- Prognostic Features of Surgical Stage I Uterine CarcinosarcomaAmerican Journal of Surgical Pathology, 2007
- Uterine carcinosarcoma: Immunohistochemical studies on tissue microarrays with focus on potential therapeutic targetsGynecologic Oncology, 2007
- The causes and consequences of cancer-associated malnutritionEuropean Journal of Oncology Nursing, 2005